期刊文献+

乙型肝炎病毒感染者特异性细胞免疫的研究进展 被引量:4

The current state on hepatitis B virus in specific cellular immune
暂未订购
导出
摘要 乙型肝炎病毒(HBV)感染呈世界流行趋势,是一个全球关注的健康问题,HBV作为一种非侵袭性嗜肝病毒,感染人体后并不直接损害肝脏,而是由其表达的抗原系统及其抗体所介导的特异性免疫反应和非特异性的以细胞因子为主的炎性介质导致的肝细胞损伤。特异性细胞免疫是清除机体内病毒的重要因素,针对HBV各类抗原表位的特异性细胞毒T淋巴细胞(CTL)作为主要的效应细胞,与病毒清除和细胞损伤有关,是当前研究的热点。本文就近年乙型肝炎病毒感染者特异性细胞免疫的研究现状作一综述。 Infection of Hepatitis B Virus(HBV)is presenting a popular trend in worldwild and has become a globle attention health problem.As a noninvasive eosinophilic liver virus,HBV doesn't directly damage the liver after infecting the body.The liver injury is resulted from the specific immune response induced by expression of antigen and antibody system and inflammations mainly mediated by non-specific cytokines.The specific cellular immune is the important factor in clearing virus.As chief effective cells,specific CTLs aimed at all kinds of epitopes are concerned with virus removing and cell damage.It is a hot spot on this field of research at present.This review article is a subjective passage for current state on hepatitis B virus in specific cellular immunity in recent years.
出处 《南通大学学报(医学版)》 2012年第1期54-57,共4页 Journal of Nantong University(Medical sciences)
关键词 乙型肝炎病毒 特异性细胞免疫 细胞毒T淋巴细胞 hepatitis B virus specific cellular immune cytotoxic T lymphocytes
  • 相关文献

参考文献15

二级参考文献142

共引文献159

同被引文献37

  • 1李明,朱传武,钱峰,王海燕,诸葛洪祥.慢性乙型肝炎患者外周血单个核细胞穿孔素表达与干扰素抗病毒疗效的关系[J].中华肝脏病杂志,2006,14(10):729-731. 被引量:8
  • 2李娟,范雪云,姚三巧,闫兆凤,白玉萍.转化生长因子-β基因多态性与尘肺相关性研究[J].工业卫生与职业病,2007,33(5):286-290. 被引量:5
  • 3中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].中华传染病杂志,2011,29(1):65-80.
  • 4Zhang Z, Zhang JY, Wang LF, et al. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection [J]. J Gastroenterol Hepatol, "2012, 27(2) :223 230. DOI: 10. llll/j. 1440-1745. 2011. 06940. x.
  • 5Li J, Han Y, Jin K, et al. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B inecion [J/OL]. Viro J, 2011, 8 : I_99 (2011-05-02) [2016- 01-10]. http: // virologyi, biomedcentral, com/articles/lO. 1186/1743-422X-8-199. DOI: 10. 1186/1743-422X-8-199.
  • 6Akbar SM, Horiike N, Onji M. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection [J]. World J Gastroenterol, 2006, 12 (18) : 2876- 2883. DOI: I0. 3748/wig. v12. i18. 2876.
  • 7Boni C, Laceabue D, Lampertico P, et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues [J]. Gastroenterology, 2012,143(4) : 963-973. DOI: 10. 1053/j. gastro. 2012.07. 014.
  • 8Honkoop P, de Man RA, Niesters HG, et al. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy [J]. Hepatology, 2000, 32 (3) :635-659. DOI 10. 1053/jhep. 2000. 16333.
  • 9Carey I, DAntiga L, Bansal S,et al. Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy [J]. J Virol, 2011,85(5) 2416- 2428. DOI 10. 1128/JVI. 01449-10.
  • 10Ishikawa T. Immunoregulation of hepatitis B virus infection-- rationale and clinical application [J]. Nagoya J Med Sci, 2012, 74(3-4) 217-232.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部